Jeito Capital
Venture capital
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
10Deep-tech portfolio8 active
2Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: Odyssey Therapeutics
8Co-investorsShare a portfolio company
Portfolio · 10 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Odyssey Therapeutics | Biotech | Active | Dec 4, 2025 | $570.8M |
| Aviceda Therapeutics | Biotech | Active | Jan 13, 2025 | $98.6M |
| Adcendo | Biotech | Active | — | — |
| Alveus Pharma | Biotech | Active | — | — |
| Azafaros | Biotech | Active | — | — |
| Basis | Biotech | Active | — | — |
| Noema Pharma | Biotech | Active | — | — |
| ReproNovo | Biotech | Active | — | — |
| EyeBio | Biotech | Acquired | — | — |
| Human Immunology Biosciences | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#48
Portfolio exits#103
Raises, 12 months#22
Co-investors#173
Co-investors
- Andera PartnersVenture capital2 shared
- Novo HoldingsVenture capital2 shared
- ForbionVenture capital1 shared
- Foresite CapitalVenture capital1 shared
- Longitude CapitalVenture capital1 shared
- Sands Capital VenturesVenture capital1 shared
- TCG CrossoverVenture capital1 shared
- Venrock Healthcare Capital PartnersVenture capital1 shared
Sectors
- Biotech10
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.